Boston Scientific Cuts Forecast on Product Slowdown and Competition
Boston Scientific beat second-quarter estimates but lowered its 2026 sales and earnings outlook as restructuring costs weighed on guidance.
Boston Scientific made more money than expected this quarter, but said it will make less money next year because some products aren't selling as well and other companies are competing harder. When a company lowers what it thinks it will earn, that's a sign to watch if their products stay strong or if problems get worse.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.